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Abstract 30 
Long-term potentiation (LTP) in the rat hippocampus is the most extensively studied cellular 31 
model for learning and memory. Induction of classical LTP involves an NMDA receptor- and 32 
calcium-dependent increase in functional synaptic AMPA receptors mediated by enhanced 33 
recycling of internalized AMPA receptors back to the postsynaptic membrane. Here we 34 
report a novel, physiologically relevant NMDA receptor-independent mechanism that drives 35 
increased AMPA receptor recycling and LTP. This pathway requires the metabotropic action 36 
of kainate receptors and activation of G-protein, protein kinase C and phospholipase C. Like 37 
classical LTP, kainate receptor-dependent LTP recruits recycling endosomes to spines, 38 
enhances synaptic recycling of AMPA receptors to increase their surface expression and 39 
elicits structural changes in spines, including increased growth and maturation. These data 40 
reveal a new and previously unsuspected role for postsynaptic kainate receptors in the 41 
induction of functional and structural plasticity in the hippocampus.  42 
Introduction 43 
The precise dynamic regulation of the number, composition and distribution of postsynaptic 44 
AMPA receptors (AMPARs) is essential for synaptic transmission and plasticity. Classical 45 
LTP, which has been characterised extensively in many brain areas, requires the activation 46 
of NMDA receptors (NMDARs) 1. An equivalent NMDAR-dependent LTP can be induced in 47 
cultured hippocampal neurons by brief exposure to the NMDAR co-agonist glycine, which 48 
elicits the insertion of AMPARs into the postsynaptic membrane and increases miniature 49 
excitatory postsynaptic currents (mEPSCs) 2.  50 
LTP involves both recycling-dependent increases in AMPAR surface expression at the post-51 
synaptic membrane and increases in dendritic spine size 3. Furthermore, stimuli that induce 52 
LTP in dispersed hippocampal neuronal cultures promote recycling and recruitment of 53 
transferrin receptor-positive recycling endosomes into spines. This repositioning of the 54 
endosomal-recycling compartment is critical for activity-dependent changes in spine 55 
morphology and provides a mechanistic link between structural and functional plasticity 3, 4. 56 
Kainate receptors (KARs) are tetrameric assemblies of combinations of GluK1 – GluK5 57 
subunits. They are present at both pre- and postsynaptic membranes where they perform 58 
distinct roles in modulating synaptic transmission, neuronal excitability and network activity 5, 59 
6, and are implicated in processes ranging from neuronal development and differentiation to 60 
neurodegeneration and neuronal cell death 5, 7. In addition to direct ionotropic signalling, 61 
KARs also signal through the activation of G proteins leading to PKC activation 5, 6, 8-10. Under 62 
physiological glutamate release conditions, postsynaptic KAR metabotropic signalling in CA1 63 
and CA3 pyramidal neurones inhibits the hyperpolarisation caused by the post-spike 64 
potassium current I (sAHP) 11-14.  65 
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We, and others, have shown previously that transient kainate (KA) stimulation modulates 66 
surface expression of KARs 15-18 via changes in Rab11-dependent recycling within spines 19. 67 
Here, we report that KA induces an NMDAR-independent increase in the synaptic surface 68 
expression of functional AMPARs, as well as the structural plasticity via a pathway that 69 
requires metabotropic signalling of postsynaptic GluK2-containing KARs and enhanced 70 
endosomal vesicle recycling in spines. 71 
Results 72 
KAR activation increases surface expression of functional synaptic AMPARs. 73 
We first investigated the effects of KA application on AMPAR surface expression in the 74 
presence of tetrodotoxin (TTX, 0.5 µM), GYKI53655 (40 µM) and L689560 (5 µM) to 75 
suppress activity-dependent glutamate release and prevent activation of AMPARs and 76 
NMDARs respectively. Agonist stimulation of KARs (10 µM KA, 3 min) significantly increased 77 
surface expression of both GluA1 and GluA2 AMPAR subunits (Fig. 1A, p=0.001 and 78 
p=0.004, respectively), without altering the total number of AMPARs (Supplementary Fig.1A-79 
B, p>0.09). This KAR-induced increase in plasma membrane expressed AMPARs was 80 
blocked by the competitive AMPAR/KAR antagonist CNQX (10 µM; Fig. 1A, p>0.9). 81 
To define if the KAR-induced increase in AMPAR surface expression occurred at spines, we 82 
immuno-labelled surface expressed GluA1 and GluA2 in non-permeabilised neurons (Fig. 83 
1B) and calculated the spine/adjacent dendrite ratio. This was increased for both GluA1 and 84 
GluA2 following KAR stimulation (p=0.001 for GluA1 and p=0.003 for GluA2), indicating 85 
preferential AMPAR surface expression in spines. Consistent with this, KAR-stimulation 86 
increased surface GluA1 and GluA2 colocalisation with the postsynaptic marker PSD95 (Fig. 87 
1C, p<0.001).  88 
The increase in synaptic GluA1 and GluA2 was induced by a brief (3 min) exposure of the 89 
cultured hippocampal neurons to all KA concentrations tested, ranging from 500 nM to 20 µM 90 
(Supplementary Fig. 1C-D, p<0.001 and p<0.001 respectively). We next tested if nanomolar 91 
concentrations of KA increased postsynaptic AMPAR-mediated mEPSCs in CA1 pyramidal 92 
neurons in hippocampal slices. KA concentrations below 3 µM do not activate AMPARs in 93 
CA1 20, but, to fully exclude direct KA activation of AMPARs, we co-applied the AMPAR 94 
specific antagonist GYKI53655 (40 µM) during the transient KA application. GYKI53655 was 95 
then washed out to obtain AMPAR mEPSCs. Co-application of GYKI53655 with 500 nM KA 96 
did not change mEPSC frequency (Supplementary Fig. 2A, p>0.3) but caused a marked 97 
increase in the amplitude of mEPSCs (Fig. 1D and Supplementary Fig. 3A, p<0.004. These 98 
data demonstrate a KAR-induced increase of functional postsynaptic AMPARs.  99 
KAR-mediated NMDAR-independent LTP. 100 
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Increased postsynaptic AMPARs surface expression underpins LTP, so we investigated the 101 
effects of KAR activation on synaptically evoked AMPAR-mediated excitatory postsynaptic 102 
responses in rat hippocampal slices. KA (10 µM, 3 min) caused a transient depression 103 
followed by a progressive increase in AMPAR-mediated CA1 EPSCs (Supplementary Fig. 104 
4A; 169.8% ± 31.4%, p=0.01) with no change in glutamate release probability determined by 105 
the paired-pulse ratio (PPR; Supplementary Fig. 4B) in the continuous presence of 100 µM 106 
APV (to block NMDARs). At this concentration, however, KA activates AMPARs and could 107 
affect their dynamics. Thus, we performed the experiment as above, but using 40 µM 108 
GYKI53655 (present prior to and during KA application to block AMPARs). Although in the 109 
presence of GYKI53655 there was a significant difference in amplitude between the control 110 
and KA conditions (KA, 100.8% ± 15.5%; Control 54.6% ± 8.0%, p=0.009; Supplementary 111 
Fig. 4C, unchanged PPRs are shown in Supplementary Fig. 4D and representative 112 
responses shown in Supplementary Fig. 4E), GYKI53655 masked the time course of 113 
AMPAR-mediated EPSCs. We therefore reduced the KA concentration to 500 nM, thereby 114 
avoiding the need to block AMPARs with GYKI53655. Under these conditions, 500 nM KA 115 
caused a progressive and persistent increase in AMPAR-mediated CA1 EPSCs (Figure 2A; 116 
133.1% ± 11.4%, p=0.02), reaching a peak approximately 10-15 min after the agonist 117 
application. Again, we found no change in PPR (Supplementary Fig. 4F, p>0.3). Combined 118 
with our mEPSC data, these evoked EPSC results indicate that KAR activation elicits 119 
NMDAR-independent KA-induced LTP via increased surface expression of postsynaptic 120 
AMPARs in CA1 hippocampal neurons.  121 
Consistent with this, KA did not induce any potentiation in AMPAR-mediated field potentials 122 
in the CA1 region of hippocampal slices from GluK2-knockout (GluK2-/-) mice (95.7 ± 3.6 %, 123 
p > 0.05, Supplementary Fig 5A). To exclude any possible developmental effects in the 124 
GluK2-knockout mice, we tested the effect of acutely blocking KARs in wild-type mice using 125 
the AMPAR/KAR blocker CNQX (10 µM) prior to and during KA challenge, followed by 126 
CNQX washout (Supplementary Fig. 5B). Compared to sham controls (CNQX only), the 127 
recovery profile was unchanged (80.2 ± 3.4 % vs. 78.7 ± 9.5 % for KA and control, p > 0.05). 128 
We also confirmed that KA application potentiated AMPAR responses in hippocampal slices 129 
obtained from adult, 3-month old mice (124.7 ± 9.6%, p < 0.01) (Supplementary Fig. 5C-D), 130 
indicating that KA-induced LTP is not developmentally restricted. 131 
Using wild-type and GluK2-knockout mice, we next examined the KAR dependency of a 132 
previously reported NMDAR-independent form of LTP evoked by high frequency stimulation 133 
(HFS) protocol, based on the modified procedure from 21, 22 (illustrated in schematic form in 134 
Fig. 2B and described in Methods). As shown in Supplementary Fig. 6A-C, field potential 135 
recordings revealed robust LTP in acute hippocampal slices from wild-type mice (185.8 ± 136 
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26.1% vs.106.1 ± 5.2% in test vs. control pathway, p=0.007), whereas a reduced LTP was 137 
obtained in GluK2-knockout mice (170.3 ± 17.3% vs.106.2 ± 5.7% in test vs. control 138 
pathway, p=0.03). To isolate the NMDAR-independent component of this LTP, we used 50 139 
µM D-APV, which completely blocked LTP in the GluK2-knockout (106.3 ± 5.0% vs. 99.4 ± 140 
4.6% in test vs. control pathway, p>0.5), but not in WT mice (128.5 ± 11.4% vs.107.7 ± 5.0% 141 
in test vs. control pathway, p<0.02). No changes in PPR were observed (Supplementary Fig. 142 
6D). These data confirm that activation of GluK2-containing KARs by synaptically released 143 
glutamate induces NMDAR-independent and KAR-dependent hippocampal LTP. 144 
Consistent with previous reports 22, the NMDAR-independent component of this HFS LTP in 145 
wild-type mice was blocked by the L-type calcium blocker nifedipine (110.45 ± 3.66% vs. 146 
104.05 ± 3.81%, p>0.05, test vs. control pathway, Supplementary Fig. 7A). As in previous 147 
experiments, no change in the PPR was detected (Supplementary Fig. 7B). 148 
Although widely used, HFS does not correspond to intrinsic in vivo patterns of hippocampal 149 
activity. Therefore, to determine if KAR-dependent LTP can be induced by more 150 
physiological stimuli, we used a protocol based on hippocampal sharp-wave/ripple-like 151 
stimulation pattern (RL-LTP; illustrated in schematic form in Fig. 2C) 23. In wild-type mice, the 152 
RL-LTP protocol resulted in a progressive potentiation that peaked 10-15 min after 153 
stimulation (Fig. 2D left panel; 166.2 ± 8.5 % vs 101.1 ± 2.9% in test vs control pathway, 154 
p<0.001). In GluK2-knockout mice (Fig. 2D right panel; representative traces in Fig. 2E), 155 
there was a significantly reduced LTP (139.7 ± 7.5 % vs.100.6 ± 2.7% in test vs. control 156 
pathway, p<0.001, and p=0.03 compared to wild-type mice, Fig. 2F). Importantly, however, 157 
while RL-LTP (although at reduced level) was still detected in wild-type mice in the presence 158 
of 50 µM D-APV (Fig 2D left panel; 120.9 ± 2.3% vs 99.5 ± 2.8% in test vs control pathway, 159 
p<0.001), RL-LTP was completely prevented in GluK2-knockout mice (99.1 ± 4.0% vs 99.2 ± 160 
3.8%, test vs control pathway, p=0.98, and p=0.002 compared to wild-type mice). 161 
D-APV is a competitive antagonist, therefore, to exclude the theoretical possibility that the 162 
intense RL-LTP stimulation paradigm could lead to glutamate accumulation in synaptic cleft 163 
that could out-compete D-APV, thereby allowing NMDAR-dependent LTP, we used a 164 
previously described strategy 24. We first blocked the NMDARs with MK-801 (20 µM), a use-165 
dependent blocker (in nominal 0 mM Mg2+ aCSF, to facilitate the NMDAR activation). Then, 166 
once the full blockade was achieved, we reintroduced ordinary aCSF, continuously 167 
supplemented with MK-801 (20 µM) and D-AP5 (50 µM). Robust potentiation still occurred in 168 
wild-type mice, further confirming the KAR-dependent component of RL-LTP (142.6 ± 0.6 vs. 169 
98.2 ± 9.3% in test vs. control pathway, p<0.01; Supplementary Fig. 7C-D).  170 
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Finally, to further discount any possible confounding developmental issues in GluK2-171 
knockout mice, we performed the RL-LTP experiment in wild-type mice while acutely 172 
blocking KARs using CNQX (10 µM, present prior to and during LTP induction, followed by 173 
washout), similarly to the approach used in Supplementary Fig. 5B. No RL-LTP was induced 174 
after full inhibition by CNQX, i.e. both test and control pathways gradually recovered with 175 
similar temporal profiles (Supplementary Fig. 7E, minutes 37-41: 20.9 ± 4.6 % vs. 22.3 ± 3.2, 176 
p > 0.05; minutes 57-61: 75.1 ± 6.00 % vs. 70.9 ± 6.46 %, p > 0.05; minutes 77-81: 100.4 ± 177 
0.7 % vs. 100.5 ± 2.6 %, p > 0.05, test vs. control pathway). These results provide 178 
compelling evidence that physiologically relevant stimulation of GluK2-containing KARs can 179 
induce NMDAR-independent LTP in the hippocampus.  180 
Next, using rat hippocampal slices, we performed within-slice comparisons of test and control 181 
pathway responses to RL-LTP and KA application. First we induced RL-LTP (normalized 182 
fEPSP slope in test and control pathway = 123.1 ± 1.8% and 98.1 ± 1.6%, respectively, 183 
p<0.001, Supplementary Fig. 8A-C). We then subjected the slice to bath application of KA 184 
(500 nM, 3 min), which caused a robust increase in control pathway to levels equivalent to 185 
the RL-LTP in the test pathway (normalized fEPSP slope in test and control pathway = 132.9 186 
± 2.4% and 131.7 ± 3.6%, respectively; p=0.78). Importantly, however, there was no further 187 
increase in the pathway previously subjected to RL-LTP. These data also demonstrate that 188 
the extent of agonist-induced LTP in field recordings is comparable to that achieved by 189 
patch-clamp recording.  190 
Our data from GluK2-/- mice indicate that LTP is not saturated in the presence of D-APV 191 
because RL-LTP induced significantly stronger LTP in WT mice. In a complementary 192 
approach, we directly tested if agonist and electrical stimulation-induced KAR-LTP share a 193 
common mechanism using a previously established occlusion protocol 25 . 194 
We initially induced RL-LTP in one pathway (black circles, Supplementary Fig. 8D, 100.9 ± 195 
2.05 % vs. 133.4 ± 10.00%, p<0.05) and then bath applied KA (500 nM, 3 min). As expected, 196 
and consistent with the data in Supplementary Fig. 8A, the pathway that had not been 197 
subjected to RL-LTP was potentiated by kainate (white circles, Supplementary Fig. 8D-E, 198 
118.1 ± 4.0 %, p < 0.01). Importantly, KA did not cause additional potentiation in the pathway 199 
previously exposed to RL-LTP (black circles, 128.0 ± 11.2 %, p > 0.05). The stimulation 200 
intensity of the test pathway (white circles) was then adjusted to normalise it to its basal level 201 
(101.6 ± 5.7 %, p > 0.05) and the RL-LTP protocol was then delivered to this pathway 202 
(Supplementary Fig. 8D-E). Since no further potentiation was observed (97.6 ± 9.3 %, p > 203 
0.05), this inverse occlusion experiment confirms that KA-induced potentiation and RL-LTP 204 
share a common mechanism.  205 
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KAR activation induces structural plasticity via enhanced endosomal recycling. 206 
NMDAR-dependent LTP elicits structural changes in spine shape and increased spine size 4. 207 
Correspondingly, transient KA application robustly increases spine density and maturity (Fig. 208 
3A-C), More specifically, there are increases in mature spine size (65.1% ± 14%, p<0.001; 209 
Fig. 3A) and numbers of dendritic protrusions (68.9% ± 25%, p<0.001; Fig. 3B), as well as 210 
enhanced transition from stubby to mushroom spines (18.7% ± 4%, p<0.001; Fig. 3C).  211 
NMDAR-dependent LTP also enhances generalised endosomal recycling of cargo proteins 212 
and membrane within the spine 3, 4. To investigate if the same mechanisms underlie KAR-213 
dependent LTP, we monitored transferrin-Alexa594 (Tf-A594) labelled recycling endosomes. 214 
Tf-A594 endosomes distribute mainly at the base of spines in non-stimulated control 215 
neurons. Following transient KA application, however, Tf-A594 endosomes translocate from 216 
the dendritic shaft to the spine head (Fig. 4A). Furthermore, expression of a dominant 217 
negative version of the recycling endosome-associated small GTPase Rab11 (Rab11dn), 218 
which blocks NMDAR-dependent LTP 26, prevented the KAR-evoked recruitment of recycling 219 
endosomes into spines (Fig. 4B) and blocked the increases in the head diameter of 220 
mushrooms spines (p<0.0001 for KA - control, and Rab11wt - Rab11dn; Fig. 4C).  221 
To confirm the role of recycling in KAR-dependent LTP, we used surface biotinylation assays 222 
in combination with primaquine to selectively inhibit recycling 27 or monensin to block both 223 
recycling and lysosomal degradation 28. As expected, both drugs prevented the KAR-induced 224 
increase in GluA1 and GluA2 surface expression (Supplementary Fig. 9A-B, p<0.001). We 225 
next quantified surface expression of GluA1 and GluA2 in spines and adjacent shaft regions. 226 
Inhibiting recycling with primaquine, monensine or Rab11dn prevented the KAR-induced 227 
change in the spine:dendrite ratio of AMPAR surface expression (Supplementary Fig. 10A-C, 228 
p=0.18 for GluA1 and p=0.24 for GluA2, p=0.80 GluA1 and p=0.34 GluA2, and p=0.03 for 229 
GluA1 and p=0.02 for GluA2). These data indicate that both NMDAR- and KAR-dependent 230 
LTP require the recruitment and enhanced recycling of endosomal vesicles in spines.  231 
KAR-dependent LTP is mediated via a non-canonical G-protein-associated signalling 232 
pathway.  233 
Although some mechanistic details are still lacking, it is now clear that KARs signal via G-234 
protein-dependent pathways to increase intracellular calcium [Ca2+]i, and activate protein 235 
kinase C (PKC) and phospholipase C (PLC) 5, 6, 9, 10, 29. Since increased [Ca2+]i is required for 236 
LTP, 30, 31 we tested the source of [Ca2+]i increase in KAR-dependent LTP using the 237 
extracellular chelator EDTA and the membrane permeant chelator BAPTA-AM. The 238 
presence of BAPTA-AM, but not EDTA, during the KA application blocked the KAR-evoked 239 
increase in synaptic AMPAR surface expression (Fig. 5A, B; controls without KA shown in 240 
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Supplementary Fig. 11A; BAPTA-AM; GluA1, p=0.5; GluA2 p= 0.10: EDTA; GluA1 p=0.009; 241 
GluA2 p<0.001) and the associated changes in the structural plasticity (Fig. 5C and 242 
Supplementary Fig. 11B, EDTA; p <0.001; BAPTA-AM p=0.61). Similarly, preincubation with 243 
PKC inhibitor chelerythrine or the PLC inhibitor U73122 blocked the KAR-induced increase in 244 
GluA1 and GluA2 expression at synapses (Fig. 5A, B; controls without KA shown in 245 
Supplementary Fig. 11A-B; U73122: GluA1 p=0.56; GluA2 p= 0.32 ; chelerythrine: GluA1 246 
p=0.54, GluA2 p= 0.78), the increase in the spine size (Fig. 5C and Supplementary Fig. 11B, 247 
U73122: p=0.42; chelerythrine: p=0.48), as well as the agonist-evoked KAR-dependent LTP 248 
in electrophysiological recordings (100.5 ± 1.4%, p > 0.05 for U73122 and 100.7 ± 5.8%, 249 
p>0.05 for chelerythrine, Fig. 5D, E). 250 
We also analysed PKC and PLC activity in cells after triggering KAR-dependent LTP. Brief 251 
KAR stimulation (3 min, 500nM) elicited a nearly 2-fold increase in PLC and PKC activity 252 
compared to unstimulated cells (Fig. 5F). Furthermore, the extent of PKC activation in KAR-253 
dependent LTP is similar to stimulation by the phorbol ester PMA (0.5 µM, 3min, p=0.4). The 254 
KAR-induced activation of PKC and PLC was prevented by CNQX and BAPTA-AM, but not 255 
by the presence of EDTA during KA application (Fig. 5F: PKC: +CNQX: p=0.037, +EDTA: 256 
p=0.81, +BAPTA-AM, p=0.002, +Chelerythrine p=0.038. For PLC: +CNQX: p=0.047, +EDTA: 257 
p=0.84, +BAPTA-AM: p=0.056, +U73122 p=0.006). Finally, in addition to EGTA (5 mM) 258 
application only during KA application, we continuously applied (30 min during and after KA 259 
application) the selective Ca2+ chelator EGTA to bind extracellular Ca2+ or nifedipine to block 260 
L-type voltage-gated Ca2+ channels (VGCCs). Continuous application of either drug 261 
prevented the KA-induced increase in GluA1 and GluA2 surface expression at synapses 262 
(Supplementary Fig. 11C, D; p<0.001), suggesting a delayed role for extracellular Ca2+ in 263 
KAR-LTP. Importantly, inhibiting Group I /II metabotropic glutamate receptors with the 264 
specific antagonist MCPG did not affect KAR-dependent increases in synaptic AMPARs or 265 
spine size. (Supplementary Fig. 12A, B; p<0.001 and p=0.018). These data demonstrate that 266 
KAR-LTP requires activation of PKC and PLC and intracellular calcium release, consistent 267 
with a KAR-mediated metabotropic signalling pathway. 268 
Furthermore, we performed the same experiments as those shown in Figure 1C, but with the 269 
preincubation in the presence of G-protein inhibitor pertussis toxin (PTX) (1 µg/mL, 1 hour). 270 
PTX prevented KA-induced activation of both PLC and PKC (Fig. 6A, p=0.03 and p=0.012 271 
respectively). PTX also blocked the increased colocalization of GluA1 and GluA2 with PSD95 272 
following the KA challenge (Fig. 6B, GluA1, p=0.93; GluA2 p=0.47, compare with Fig. 1C). 273 
Furthermore, incubation of hippocampal slices with PTX prior to recording mEPSCs 274 
prevented the KAR-induced increase in AMPAR mEPSC amplitude in CA1 pyramidal 275 
neurons (Fig. 6C, p=0.34, compare with Fig. 1D), with no change in the frequency 276 
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(Supplementary Fig. 13A p>0.1). Correspondingly, agonist-evoked and electrically stimulated 277 
KAR-dependent LTP (Fig. 6D-E and Supplementary Fig. 13B-D, p=0.69 and p=0.3, compare 278 
with Fig. 2A), as well as structural plasticity (Fig. 6F and Supplementary Fig. 13E, p=0.4, 279 
compare with Fig. 3A) were prevented by preincubation with PTX, again indicating the 280 
requirement for a metabotropic action for KARs.  281 
Both our imaging and functional data using nifedipine suggest that following initial LTP 282 
induction that requires intracellular Ca2+, extracellular calcium entry through L-type VGCCs 283 
plays a role in maintaining KAR-LTP. Moreover, VGCC currents can be modulated by G-284 
protein activation 32. We therefore used patch-clamp electrophysiology to measure VGCC 285 
Ca2+ currents. KA application (500 nM, 3 min) increased VGCC currents in control conditions 286 
(127.4 ± 16.1%, n = 5), but there was no increase in slices that had been preincubated with 287 
PTX (90.4 ± 4.5%, n = 4, p < 0.05, Supplementary Fig. 14). 288 
Substitution of extracellular Na+ with an equimolar concentration of the non-permeant cation 289 
N-methyl-D-glucamine (NMDG) prevents KAR channel conductance, but does not impede 290 
metabotropic KAR activity 9. Replacing Na+ with NMDG does not block the KAR-induced 291 
increase in GluA1 and GluA2 colocalization with PSD95 and spine size (Supplementary 292 
Fig.15A-B; GluA1, p= 0.004, GluA2, p <0.001and p=0.009 for spine size), further confirming 293 
that ionotropic activity is not required for KAR-dependent LTP. The KAR antagonist UBP310 294 
has been reported to inhibit KAR ionotropic activity, but not KAR-metabotropic signalling, via 295 
a mechanism that likely involves an action beyond simple competitive antagonism 33. This 296 
effect is unlikely to be due to different subunit compositions since most KARs in the brain 297 
comprise GluK2/5 combinations.  We anticipate that future studies will uncover the 298 
mechanisms underlying this selective inhibition of ionotropic over metabotropic KAR activity. 299 
Nonetheless, consistent with the documented selectively ionotropic action,UBP310 (10 µM) 300 
did not block KA-induced increases in PLC and PKC activity (Fig. 7A, p= 0.74 and p=0.94 301 
compared to KA) nor did it prevent KAR-dependent LTP (Fig. 7B-C and Supplementary 302 
Fig.15C-D p=0.01 and p=0.006) and structural spine plasticity (Fig.7D, p=0.03) ).  303 
Taken together, this array of complementary and mutually supportive data provide 304 
compelling evidence that KAR channel activity is not required for KAR-dependent LTP, but is 305 
instead underpinned by KAR-mediated metabotropic signalling.  306 
Discussion 307 
Here we report that KAR activation can elicit a previously unanticipated form of NMDAR-308 
independent LTP. This occurs via a metabotropic KAR pathway that recruits endosomal 309 
recycling machinery from the dendritic shaft into the spine to alter post-endocytic GluA1 and 310 
GluA2 sorting and exocytosis back to the spine plasma membrane. 311 
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KAR activation increases AMPAR surface expression at postsynapse 312 
We have shown previously that transient KA application can increase KAR surface 313 
expression 16 and enhance spine growth by altering post-endocytic sorting and enhanced 314 
recycling mechanisms 19. Furthermore, KARs regulate neurite outgrowth 16, 34, 35, as well as 315 
filopodia and nascent spinule development 36. Here we show that transient KAR activation 316 
augments recycling and surface expression of AMPARs, increases AMPAR colocalisation 317 
with PSD95 in spines and increases the amplitude of AMPAR mEPSCs. Consistent with 318 
postsynaptic mechanisms, the probability of neurotransmitter release was unchanged. 319 
Furthermore, using two different stimulation protocols, we demonstrate that synaptic 320 
activation of GluK2-containing KARs underlies the increases in the evoked AMPAR-mediated 321 
responses. These results reveal a novel and physiologically relevant form of postsynaptic 322 
KAR-dependent, NMDAR-independent LTP. 323 
KAR activation increases synaptic recycling and spine size  324 
In parallel with increased AMPAR-mediated neurotransmission, NMDAR-dependent LTP 325 
elicits the formation and enlargement of dendritic spines to consolidate neural circuitry 37, 38. 326 
Recycling endosomes are recruited to deliver membrane material directly within spines for 327 
structural plasticity 3, 4, providing a mechanistic link for coupling changes in spine size to the 328 
regulation of AMPAR-mediated transmission and LTP 39. Like NMDAR-dependent LTP, KAR-329 
dependent LTP requires translocation of Rab11-positive recycling endosomes from the 330 
dendritic shaft into spines. Moreover, overexpression of dominant negative Rab11, which 331 
blocks NMDAR-dependent LTP 40, prevents the KAR-evoked redistribution of recycling 332 
endosomes to spines and blocks KAR-dependent LTP. This involvement of Rab11 in 333 
NMDAR-dependent and KAR-dependent LTP indicates shared mechanisms in both 334 
pathways.  335 
Metabotropic actions of KARs mediate KAR-dependent LTP 336 
Metabotropic KAR signalling was first identified through the KAR-mediated modulation of 337 
GABA release, which does not require KAR channel activation, but is prevented by inhibition 338 
of G-protein and PKC activity 8. Subsequently, KAR-dependent inhibition of the slow after-339 
hyperpolarizing potential (sAHP), which enhances neuronal excitability, was also shown to 340 
be mediated by metabotropic KAR signalling 11. Although there is now a wealth of 341 
experimental support for metabotropic action of both pre- and postsynaptic KARs (for 342 
reviews see 5, 6, 41), many questions remain. For example, the identity of the KAR subunit 343 
conferring metabotropic action is unclear because the literature is contradictory and no KAR 344 
subunits contain conventional G-protein binding motifs. Nonetheless, it is now generally 345 
accepted that metabotropic KAR signalling is PTX sensitive and thus involves Go rather than 346 
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Gq protein activation. Accordingly, a recent report has suggested that the KAR subunit 347 
GluK1 can associate directly with a Go protein α subunit and that this association is 348 
responsible for the metabotropic effects of KARs 10. Our results now reveal an entirely novel 349 
role for metabotropic KAR signalling in regulating AMPAR trafficking, spine morphology and 350 
NMDAR-independent LTP.  351 
KAR-dependent LTP  352 
LTP at CA1 hippocampal synapses is not uniform and comprises a range of NMDAR-353 
dependent and -independent plasticity mechanisms 42. Given the crucial importance of 354 
plastic changes in the brain, this array of pathways provides a dynamic, flexible and reliable 355 
system to ensure the continuity of neuronal network and brain function. Our identification of a 356 
novel postsynaptic KAR-dependent LTP adds to these important system traits. Ripple-like 357 
high-frequency patterns of activity (~200 Hz for ~100 ms, repeating at ~1 Hz) occur in 358 
immobile awake animals and during slow wave sleep 43. These patterns generally occur in 359 
conjunction with large-amplitude sharp waves and ripple-related activity in vivo is implicated 360 
in LTP that underlies memory consolidation in the hippocampus 44, 45. Here, we show for the 361 
first time that this strong and physiologically relevant ripple-like activity LTP induction 362 
protocol (RL-LTP) is mediated via GluK2-containing KARs. 363 
It is notable that the induction of KAR-LTP and the previously reported agonist-evoked 364 
increase in surface expression of GluK2-containing KARs share a similar time course that 365 
reaches a plateau 10-15 min after stimulation 16. This profile correlates with the delayed 366 
NMDAR-independent component of HFS-induced LTP 21 and shares dependency on VGCC 367 
activation. Moreover, G-protein potentiation of VGCC activity is sensitive to PTX and requires 368 
PKC activation and increases in [Ca2+]i 32, consistent with KAR-metabotropic actions 369 
modulating VGCC activity in NMDAR-independent LTP. These features are similar to the role 370 
of mGluR5 receptor metabotropic signalling which, by facilitating L-type VGCC activity via 371 
intracellular Ca2+ release, contributes to NMDAR-independent forms of LTP 46. It is important 372 
to note that the rise in [Ca2+]i, presumably mediated via IP3 receptors, can facilitate VGCC 373 
activity and that VGCC activity and the influx of extracellular calcium can prolong the 374 
temporal profile and frequency of intracellular Ca2+-release events 47. This reciprocal 375 
feedback system fits with our imaging and electrophysiological experiments with nifedipine 376 
and can extend beyond the kainate stimulation. We anticipate that future work will explore 377 
this feedback system in more detail by combining simultaneous multiphoton imaging and 378 
electrophysiology in brain slices. 379 
Concluding remarks 380 
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Here we describe an entirely new pathway in which direct activation of postsynaptic KARs 381 
induces LTP. These data show that KAR metabotropic signalling facilitates information 382 
transfer and synaptic integration by two parallel mechanisms, namely the short-term 383 
regulation of excitability 13, 14 and long term increase in synaptic efficacy via LTP. Both 384 
mechanisms are induced by high frequency stimulation of KARs and require PKC. Given that 385 
KARs are highly expressed during the neuronal circuit formation, and that their dysfunction is 386 
implicated in many neurological diseases including epilepsy 48 and intellectual disability 49, 387 
we anticipate that our findings will have far reaching implications. 388 
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Figure Legends 549 
 550 
Fig 1. KA increases AMPAR surface expression. 551 
A, Immunoblots show the KA-evoked increased surface expression of GluA1 and GluA2, 552 
which was blocked by CNQX. Data were quantified as % of control,  n=3 independent 553 
experiments. Dot-plots on the right indicated values for the individual experiments. Unless 554 
otherwise indicated, all imaging and biochemistry experiments are performed in the 555 
continuous presence of TTX (0.5 µM), GYKI53655 (40 µM) and L689560 (5 µM).  556 
B, Confocal images showing surface GluA1 and GluA2 in the dendritic shaft and spine (scale 557 
bar 1 µm) and cumulative frequency plots of spine/dendrite ratios. n=11-16 cells per 558 
condition, 3 independent experiments.  559 
C, Co-localization of GluA1 or GluA2 (red) and PSD95 (green). Scale bar 1 µm. Graphs 560 
show Pearson´s coefficients for the co-localization. The black line in the whisker plot boxes 561 
indicates the median. n=10-15 cells per condition, 3 independent experiments.  562 
D, mEPSCs from CA1 pyramidal cells in hippocampal slices in the continuous presence of 563 
APV and ± GYKI and ± KA. Quantification of the data using cumulative distribution plots of 564 
mEPSC amplitudes and whisker plots. n=4 cells for control, n=5 cells for KA from n=4 565 
animals.  566 
In all experiments shown in B, C and D, data acquisition and analysis were performed in 567 
blind with respect to the treatment. 568 
 569 
Fig 2. KAR activation induces LTP. 570 
A, Effects of KA on normalized evoked EPSC amplitudes and sample traces from CA1 571 
neurons in the presence of D-APV in mice hippocampal slices. n=5 cells from 5 animals for 572 
control and n=6 cells from 6 animals for kainate.  573 
B-C, Schematic representations of the HFS and the RL-LTP induction protocols. 574 
D, Normalized fEPSP slope in WT and GluK2-/- mice subjected to RL-LTP. The symbols for 575 
experiments without APV are squares (black for control and white for test pathway), whereas 576 
for experiments with APV the symbols are circles (black for control and white for test 577 
pathway). Arrow indicates point of RL-LTP stimulation. WT: n=8 slices from 8 animals; WT + 578 
AP5: n=9 slices from 3 animals; GluK2-/-: n=8 slices from 8 animals; GluK2-/- + AP5 n= 8 579 
slices from 8 animals.  580 
E, Representative traces for D.  581 
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F, Normalized fEPSP slope values 21-30 min post LTP protocol.  582 
In all experiments shown in B, C and D, data acquisition and analysis were performed in 583 
blind with respect to the treatment or genotype of the animal. 584 
 585 
Fig 3. KAR-LTP induces structural plasticity. 586 
A, KAR-induced increase in spine size. Right panel shows quantification of spine area after 587 
KA (A) / area before KA (A0) versus time. The period of KA application is indicated by the 588 
black bar. n=4-6 cells per condition, 3 independent experiments, Scale bars 1 µm.  589 
B-C, Time-lapse experiments showing KA-induced increase in the number of protrusions and 590 
enhanced transition from stubby to mushroom spines. The number of protrusions was 591 
quantified before KA application (N0) and at the indicated times (N) in 10 mm segments of 592 
dendrites ± KA. The period of KA application is indicated by the black bar. n=3-6 cells per 593 
condition, 3 independent experiments. Scale bars 4 µm.  594 
In all experiments, data analysis was performed in blind with respect to the treatment. 595 
 596 
Fig 4. KAR-LTP recruits rab11-recycling endosomes to spines. 597 
A, KA (red arrow) recruits transferrin-Alexa594 (red) labelled recycling endosomes to spines. 598 
GFP was expressed to visualise morphology. Time is indicated in seconds. Right panel 599 
shows the quantification of the proportion of endosomes in head or shaft, n=5-6 cells per 600 
condition, 3 independent experiments. Scale bar 1 µm.  601 
B, Dominant negative Rab11 prevents recruitment of recycling endosomes into spines. Tf-602 
A488 positive endosomes (green) in neurons expressing RFP-rab11wt or dn (red). n=6-8 603 
cells per condition, 3 independent experiments. Scale bar 1 µm.  604 
C, Images of spines before (t=0) and 30 min (t=30) after KA +/- CNQX in neurons expressing 605 
GFP, Rab11wt or Rab11dn. Frequency distribution plots of individual spine diameters before 606 
(black, t=0) and after (grey dotted line, t=30 min) KA. n=4-5 cells per condition, 3 607 
independent experiments. Scale bar 1 µm.  608 
In all experiments, data analysis was performed in blind with respect to the treatment. 609 
 610 
Fig 5. KAR-LTP requires intracellular calcium increase, PKC and PLC activation. 611 
A-B, BAPTA-AM, U73122 and chelerythrine, but not EDTA, block KAR-mediated increase in 612 
co-localization of surface GluA1 or GluA2 (red) and PSD95 (green). Scale bar 1 µm. Box-613 
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and-whisker plots show range of Pearson´s coefficient of controls (see also Supplementary 614 
Fig. 5) and KA treated cells (KA). Black line in the boxes indicates the median. n=6-15 cells 615 
per condition, 3 independent experiments. Data analysis was performed in blind with respect 616 
to the pharmacological treatment. 617 
C, Images of spines before (t=0) and 30 min (t=30) after indicated drugs +/- KA. 618 
Corresponding graphs on the right show frequency distribution of individual spine diameters 619 
before (black, t=0) and after (grey dotted line, t=30 min) KA. n=4 cells per condition, 3 620 
independent experiments. Note that extracellular chelation of calcium by EDTA does not 621 
prevent KAR-mediated increase in structural plasticity. Data analysis was performed in blind 622 
with respect to the pharmacological treatment. 623 
D-E, Effects of KA on normalized evoked EPSC amplitudes and sample traces from CA1 624 
neurons in the presence of chelerythrine (upper panel) or the PLC inhibitor U-73122 (bottom 625 
panel) in mice hippocampal slices. n=6 slices from 2 animals for chelerythrine and n=7 slices 626 
from 2 animals for U-73122.  627 
F, Box-and-whisker plots show range of fold increase in PLC (right) and PKC (left) activity 628 
after KA challenge. PLC or PKC activity was normalized to controls in the presence of the 629 
indicated drugs. Black line in the boxes indicates the median. n=4-6 independent 630 
experiments.  631 
 632 
Fig 6. KAR-LTP requires KAR metabotropic signalling. 633 
A, Box-and-whisker plots show range of  fold increase in PLC (right) and PKC (left) in cells 634 
preincubated with PTX. PLC or PKC activity was normalized to control and performed in 635 
parallel with the experiment in figure 5C. Black line in the boxes indicates the median. n=4-6 636 
independent experiments.  637 
B, Co-localization of surface GluA1 or GluA2 (red) and PSD95 (green). Scale bar 1 µm. Box-638 
and-whisker plots of Pearson´s coefficients of colocalization indicate that the metabotropic 639 
pathway inhibitor PTX blocks KAR-evoked increase in surface AMPARs. Black line in the 640 
boxes indicates the median.  n=9-13 cells per condition, 3 independent experiments.  641 
C, PTX blocks KAR-mediated increase in CA1 mEPSC amplitude (compare to Fig. 1D). n=3 642 
cells from 3 animals. Examples of traces pretreated with PTX before and after GYKI53655 643 
(control) and shown before and after KA plus GYKI53655 (KA+GYKI). Graphs show 644 
cumulative frequency distribution of mEPSC amplitudes and box-and-whisker plots in insets 645 
indicating range.  646 
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D, Preincubation with PTX impaired the KA-induced increase of normalized evoked EPSC 647 
amplitudes in WT mice hippocampal slices (compare with Fig. 2A). Sample traces are shown 648 
before and after KA challenge. n=6 cells from 3 animals per condition.  649 
E, Normalized fEPSP slope recorded in WT-mice hippocampal slices pretreated with PTX. 650 
Arrow indicates point of LTP induction. n=7 slices from 4 animals. 651 
F, Images of spines before (t=0) and 30 min (t=30) after KA in cells treated with PTX. 652 
Frequency distribution of individual spine diameters before (black, t=0) and after (red, t=30 653 
min) KA. n=3 cells per condition, 3 independent experiments.  654 
In all experiments data analysis was performed in blind with respect to the treatment. 655 
 656 
Fig 7. KAR-LTP does not require ionotropic KAR activation. 657 
A, Box-and-whisker plots show fold increase in PLC (right) and PKC activity (left) in the 658 
presence of the ionotropic KAR inhibitor UBP310 (10 µM). PLC or PKC activity was 659 
normalized to control and performed in parallel with the experiments in figure 5C. Black line 660 
in the boxes indicates the median. n=6 independent experiments.  661 
B, UBP310 (10 µM) did not impair the KA-induced increase of normalized evoked EPSC 662 
amplitudes in WT mice hippocampal slices (compare with Fig. 2A). Sample traces are shown 663 
before and after KA challenge. n=5 cells from 4 animals. 664 
C, Normalized fEPSP slope recorded in WT mice hippocampal slices in the presence of 665 
UBP310 (10 µM). Arrow indicates time point of LTP induction. n=11 slices per condition from 666 
6 animals. 667 
D, Images of spines before (t=0) and 30 min (t=30) after KA in cells treated UBP310 (10 µM). 668 
Frequency distribution of individual spine diameters before (black, t=0) and after (red, t=30 669 
min) KA. n=4-6 cells per condition, 3 independent experiments. Data analysis was performed 670 
in blind with respect to the pharmacological treatment. 671 
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